NCT03624751View on ClinicalTrials.gov

Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

June 30, 2018

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2030

Conditions
Thyroid Cancer
Interventions
RADIATION

radioiodine

Patients with thyroid cancer need to choose between Thyrogen® injection and Eltroxin® withdrawal before radioiodine therapy or scan.

Trial Locations (1)

407

RECRUITING

Division of Endocrinology and Metabolism in Taichung Veterans General Hospital, Taichung

All Listed Sponsors
lead

Taichung Veterans General Hospital

OTHER